Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers

Inclusion Criteria: * Between 20aged and 45aged in healthy males * Over 55kg and BMI: 18.5\~25 kg/m2 * Agreement with written informed consent Exclusion Criteria: * Subject with symptoms of acute disease at the time of screening * Clinically significant cardiovascular system, pulmonary system, renal system, endocrine system, blood system, gastrointestinal system, nervous system, mental disease or malignant tumor * Subject with known for gastrointestinal disease or surgical history which affect on absorption of drug * An impossible one who participates in clinical trial by result of screening tests * Inadequate result of laboratory test AST/ALT \> 1.5 x UNL Total bilirubin \> 1.5 X UNL * Clinically significant allergic disease(Except for mild allergic rhinitis seems to be not need for medication) * Subject with known for hypersensitivity reaction to imatinib analog * Subject with known for history which drug abuse or show positive for it in screening tests * Previously participate in other trial within 60 days * Previously make whole blood donation within 60 days or component blood donation within 30 days * Previously have blood transfusion within 30 days * Not able to taking the institutional standard meal * Subject who have had abnormal eating which affect on the ADME of drug * Not able to taking the grapefruit-containing foods * Taking ETC(ethical the counter)medicine including oriental medicine within 14 days or taking OTC(over the counter)medicine or vitamin preparations within 7 days * Continued to be taking caffein(caffein\>5cup/day), drinking (alcohol\>30g/day) and severe heavy smoker(cigarette\>1/2pack/day) * An impossible one who participates in clinical trial by investigator's decision including for reason laboratory test result